DECOUDREAUX ALECIA A 4

What Happened Alecia A. Decoudreaux, a director of CVS Health (CVS), was granted 1,447.504 deferred stock units on 2026-05-14 at a market value of $97.15 per unit, for a total value of $140,625. The transaction is coded "A" (award/grant) and is reported as a derivative award (deferred stock units), not an open-market purchase of common shares.

Key Details

• Transaction date: 2026-05-14; Form 4 filed: 2026-05-15 (timely filing).
• Award: 1,447.504 deferred stock units @ $97.15 each; total value reported $140,625.
• Transaction code: A (award/grant); security type: derivative (deferred stock units).
• Shares owned after transaction: not specified in the filing.
• Footnotes:
  • F1: Units consist of deferred stock units issued for deferral of a semi-annual director retainer under the Issuer's 2017 Incentive Compensation Plan.
  • F2: Each deferred stock unit will convert into one share of common stock and be issued in the future as elected by the reporting person.
• No indication this was an exercise, sale, gift, or a 10b5-1 plan transaction.

Context Deferred stock units are a form of compensation for non-employee directors and represent a claim to receive common shares in the future (each unit converts to one share when elected). Such awards are routine director compensation and should be viewed as compensation-related, not an immediate bullish or bearish open-market trade.